Evidence map›Paper›PMID 34344917›Full record

ArticleScientific reports2021

Probing an Ixodes ricinus salivary gland yeast surface display with tick-exposed human sera to identify novel candidates for an anti-tick vaccine.

Jos J A Trentelman, Julen Tomás-Cortázar, Sarah Knorr, Diego Barriales, Ondrej Hajdusek, Radek Sima, Jasmin I Ersoz, Sukanya Narasimhan, Erol Fikrig, Ard M Nijhof and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in cellular and infection microbiology · 2024
    Article
  4. Tick Vaccines and Concealed versus Exposed Antigens.Pathogens (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Frontiers in microbiology · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 6 countries.

Jos J A TrentelmanCenter for Experimental and Molecular Medicine, Amsterdam Multidisciplinary Lyme Borreliosis Center, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. j.j.trentelman@amsterdamumc.nl.
Julen Tomás-Cortázar *CIC bioGUNE-Basque Research and Technology Alliance, 48160, Derio, Spain.
Sarah Knorr *Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Diego BarrialesCIC bioGUNE-Basque Research and Technology Alliance, 48160, Derio, Spain.
Ondrej HajdusekBiology Centre, Institute of Parasitology, Czech Academy of Sciences, Ceske Budejovice, Czech Republic.
Radek SimaBiology Centre, Institute of Parasitology, Czech Academy of Sciences, Ceske Budejovice, Czech Republic.
Jasmin I ErsozCenter for Experimental and Molecular Medicine, Amsterdam Multidisciplinary Lyme Borreliosis Center, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Sukanya NarasimhanSection of Infectious Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA.
Erol FikrigSection of Infectious Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA.
Ard M NijhofInstitute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Juan AnguitaCIC bioGUNE-Basque Research and Technology Alliance, 48160, Derio, Spain.
Joppe W HoviusCenter for Experimental and Molecular Medicine, Amsterdam Multidisciplinary Lyme Borreliosis Center, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Academic Medical Center · NLCIC bioGUNE · ESCzech Academy of Sciences, Biology Centre · CZFreie Universität Berlin · DEYale University · USIkerbasque · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Europe, Ixodes ricinus is the most important vector of human infectious diseases, most notably Lyme borreliosis and tick-borne encephalitis virus. Multiple non-natural hosts of I. ricinus have shown to develop immunity after repeated tick bites. Tick immunity has also been shown to impair B. burgdorferi transmission. Most interestingly, multiple tick bites reduced the likelihood of contracting Lyme borreliosis in humans. A vaccine that mimics tick immunity could therefore potentially prevent Lyme borreliosis in humans. A yeast surface display library (YSD) of nymphal I. ricinus salivary gland genes expressed at 24, 48 and 72 h into tick feeding was constructed and probed with antibodies from humans repeatedly bitten by ticks, identifying twelve immunoreactive tick salivary gland proteins (TSGPs). From these, three proteins were selected for vaccination studies. An exploratory vaccination study in cattle showed an anti-tick effect when all three antigens were combined. However, immunization of rabbits did not provide equivalent levels of protection. Our results show that YSD is a powerful tool to identify immunodominant antigens in humans exposed to tick bites, yet vaccination with the three selected TSGPs did not provide protection in the present form. Future efforts will focus on exploring the biological functions of these proteins, consider alternative systems for recombinant protein generation and vaccination platforms and assess the potential of the other identified immunogenic TSGPs.

Indexed as

AnimalsAntigensBorrelia burgdorferiCattleCell Surface Display TechniquesFemaleHumansImmunizationIxodesLyme DiseaseMalePeptide FragmentsPeptide LibraryRabbitsSaccharomyces cerevisiaeSalivary GlandsAntigensPeptide FragmentsPeptide LibrarySalivary Proteins and Peptides

Identifiers

PMID34344917
PMCPMC8333314
OpenAlexW3187774023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.